Fizurex™

Steel's first product candidate is Fizurex™, a single use, disposable wipe that utilizes a combination therapy (nifedipine & lidocaine) commonly compounded by pharmacists in cream form.

Research has shown the effectiveness of the nifedipine & lidocaine combination. The compounds increase blood flow and relax the anal sphincter which, in turn, can lead to healing rates of nearly 90%. Such compelling clinical evidence has made these drugs the treatment of choice for physicians.

By dosing effective treatment in a more patient-friendly format and securing FDA approval, Steel will drastically increase access to this life changing therapy.

We are committed to leveraging our team’s insights from compounding pharmacy to take other life changing therapies from backrooms to bedsides. In the process, we are committed to improving the safety of these drugs and ensuring that they are accessible to patients at scale.